Genetic Factors in Drug-Resistant Epilepsy
Author Information
Author(s): Kumari Ritu, Lakhan Ram Garg, Kalita J, Misra U. K, Mittal Balraj
Primary Institution: Sanjay Gandhi Postgraduate Institute of Medical Sciences
Hypothesis
The study investigates the role of genetic polymorphisms in drug metabolism and transport in patients with drug-resistant epilepsy.
Conclusion
Pharmacogenetic variants significantly influence drug resistance in epilepsy, highlighting the need for personalized treatment approaches.
Supporting Evidence
- 128 patients had multiple drug-resistant epilepsy, while 274 were drug-responsive.
- CYP2C9 c.1075 A>C showed a marginally significant difference in drug response.
- ABCB1 c.2677G>T/A allele A was associated with drug resistance.
- SCN2A c.56 G>A variant frequency was higher in drug-resistant patients.
Takeaway
Some people with epilepsy don't respond to medicine because of their genes, and understanding these genes can help doctors find better treatments.
Methodology
The study involved genotyping 10 candidate gene polymorphisms in 402 epilepsy patients, comparing drug-resistant and drug-responsive groups using logistic regression.
Potential Biases
Potential biases may arise from the selection criteria and the reliance on patient records for historical data.
Limitations
The study's retrospective design and the potential for genetic heterogeneity may limit the generalizability of the findings.
Participant Demographics
70.8% male, mean age 24.30 years.
Statistical Information
P-Value
0.03
Confidence Interval
95% CI = 0.10-0.93
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website